Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong Robert Ashworth?

Dr. Robert W. Ashworth

Direct Phone: (609) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Otsuka America Pharmaceutical Inc

508 Carnegie Center

Princeton, New Jersey 08540

United States

Company Description

OAPI commercializes Otsuka-discovered and in-licensed products in North America. OPDC clinically develops and registers innovative healthcare products on a global basis. OMML is a basic research center investigating pharmacological compounds. OAPI, ... more

Find other employees at this company (2,833)

Background Information


Bachelor of Science degree


St. John's University


Web References (12 Total References)

Robert Ashworth, ... [cached]

Robert Ashworth, Ph.D. Vice President, Global Regulatory Affairs

Otsuka Corporate [cached]

Robert Ashworth, Ph.D. Vice President, Global Regulatory Affairs

Welcome to Otsuka Pharmaceutical Development & Commercialization, Inc. [cached]

Robert Ashworth, Ph.D. Vice President, Global Regulatory Affairs

Robert Ashworth, Ph.D. Vice President, Global Regulatory Affairs
Robert Ashworth is Vice-President, Global Regulatory Affairs at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), where he is responsible for leading regulatory affairs initiatives for investigational and marketed products and overseeing the regulatory interactions with external partners.
Dr. Ashworth has a lengthy record of achievement reflecting more than 30 years of experience, from chemistry research to corporate quality and compliance and regulatory affairs. His drug development and regulatory experience includes small molecules, biologic proteins and antibodies.
Prior to joining Otsuka in December 2010, he served as Vice-President, Regulatory Affairs at Biovail Corporation and, before that, he was Vice President, Regulatory Affairs and Corporate Quality at Forest Laboratories, Inc. He also held positions of increasing responsibility at BASF (Knoll Pharmaceutical Company) and Ciba-Geigy Corporation.
Dr. Ashworth received a Bachelor of Science degree in chemistry from St. John's University (New York) and a Ph.D. in organic chemistry from the Massachusetts Institute of Technology.

Robert ... [cached]

Robert Ashworth Vice-President, Global Regulatory Affairs,NPS Pharmaceuticals, Inc.

In accepting the award, Dr. Robert ... [cached]

In accepting the award, Dr. Robert Ashworth, Biovails Vice-President, Regulatory Affairs said, This award to Biovail represents the culmination of a collaborative effort among investigators, patient advocacy groups, industry and FDA. We gratefully acknowledge the contribution of another honoree, the Huntington's Disease Society of America, in educating patients and caregivers about the appropriate use of Xenazine.

Dr. Ashworth added, The greatest validation of efforts in drug development derives from satisfying an unmet medical need.

Similar Profiles

Other People with this Name

Other people with the name Ashworth

Leslie Ashworth
Oakville Symphony Orchestra

Cat Ashworth
Rochester Institute of Technology

Philip Ashworth
Rekoop Limited

Pauline Ashworth
Argyll Training Ltd

Nigel Ashworth
Argyll Training Ltd

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory